772 related articles for article (PubMed ID: 15344951)
1. Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting list.
Fisher RA; Maluf D; Cotterell AH; Stravitz T; Wolfe L; Luketic V; Sterling R; Shiffman M; Posner M
Clin Transplant; 2004 Oct; 18(5):502-12. PubMed ID: 15344951
[TBL] [Abstract][Full Text] [Related]
2. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome.
Graziadei IW; Sandmueller H; Waldenberger P; Koenigsrainer A; Nachbaur K; Jaschke W; Margreiter R; Vogel W
Liver Transpl; 2003 Jun; 9(6):557-63. PubMed ID: 12783395
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation.
Lu DS; Yu NC; Raman SS; Lassman C; Tong MJ; Britten C; Durazo F; Saab S; Han S; Finn R; Hiatt JR; Busuttil RW
Hepatology; 2005 May; 41(5):1130-7. PubMed ID: 15841454
[TBL] [Abstract][Full Text] [Related]
4. Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list.
Yao FY; Bass NM; Nikolai B; Davern TJ; Kerlan R; Wu V; Ascher NL; Roberts JP
Liver Transpl; 2002 Oct; 8(10):873-83. PubMed ID: 12360427
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma: strategy for optimizing surgical resection, transplantation and palliation.
Fisher RA; Maroney TP; Fulcher AS; Maluf D; Clay JA; Wolfe LG; Dawson S; Cotterell A; Stravitz RT; Luketic VA; Shiffman M; Sterling RK; Posner MP
Clin Transplant; 2002; 16 Suppl 7():52-8. PubMed ID: 12372045
[TBL] [Abstract][Full Text] [Related]
6. Multimodality treatment for early-stage hepatocellular carcinoma: a bridging therapy for liver transplantation.
Ashoori N; Bamberg F; Paprottka P; Rentsch M; Kolligs FT; Siegert S; Peporte A; Al-Tubaikh JA; D'Anastasi M; Hoffmann RT; Reiser MF; Jakobs TF
Digestion; 2012; 86(4):338-48. PubMed ID: 23207185
[TBL] [Abstract][Full Text] [Related]
7. Validation of the HCC-MELD for dropout probability in patients with small hepatocellular carcinoma undergoing locoregional therapy.
Huo TI; Huang YH; Su CW; Lin HC; Chiang JH; Chiou YY; Huo SC; Lee PC; Lee SD
Clin Transplant; 2008; 22(4):469-75. PubMed ID: 18318736
[TBL] [Abstract][Full Text] [Related]
8. Pre-transplant treatment of hepatocellular carcinoma: assessment of tumor necrosis in explanted livers.
Wong LL; Tanaka K; Lau L; Komura S
Clin Transplant; 2004 Jun; 18(3):227-34. PubMed ID: 15142041
[TBL] [Abstract][Full Text] [Related]
9. Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation.
Heckman JT; Devera MB; Marsh JW; Fontes P; Amesur NB; Holloway SE; Nalesnik M; Geller DA; Steel JL; Gamblin TC
Ann Surg Oncol; 2008 Nov; 15(11):3169-77. PubMed ID: 18696158
[TBL] [Abstract][Full Text] [Related]
10. A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy.
Yao FY; Bass NM; Nikolai B; Merriman R; Davern TJ; Kerlan R; Ascher NL; Roberts JP
Liver Transpl; 2003 Jul; 9(7):684-92. PubMed ID: 12827553
[TBL] [Abstract][Full Text] [Related]
11. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation.
Yao FY; Hirose R; LaBerge JM; Davern TJ; Bass NM; Kerlan RK; Merriman R; Feng S; Freise CE; Ascher NL; Roberts JP
Liver Transpl; 2005 Dec; 11(12):1505-14. PubMed ID: 16315294
[TBL] [Abstract][Full Text] [Related]
12. Transarterial chemoembolization for HCC in patients with extensive liver transplantation waiting times.
Eswaran SL; Pierce K; Weaver F; Rogers T; Brems JJ; Sontag SJ; Borge M
Angiology; 2012 Apr; 63(3):206-12. PubMed ID: 21733955
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of hepatocellular carcinoma locoregional therapies on patients waiting for liver transplantation.
Moreno Planas JM; López Monclús J; Gómez Cruz A; Rubio González E; Pérez Arangüena R; Boullosa Graña E; Garcia Suárez A; Pérez-Picouto JL; Fernández Ruiz M; Lucena de la Poza JL; Sánchez Turrión V; Cuervas-Mons Martínez V
Transplant Proc; 2005 Apr; 37(3):1484-5. PubMed ID: 15866648
[TBL] [Abstract][Full Text] [Related]
14. [Influence of treatment of hepatocellular carcinoma before liver transplantation on post transplant tumor recurrence and survival].
Díaz-Sánchez A; Matilla A; Núñez O; Merino B; Peligros I; Rincón D; Salcedo M; Lo Iacono O; Vega Catalina M; Clemente G; Bañares R
Gastroenterol Hepatol; 2010 Mar; 33(3):155-64. PubMed ID: 19945770
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency ablation of hepatocellular carcinoma as bridge therapy to liver transplantation: A 10-year intention-to-treat analysis.
Lee MW; Raman SS; Asvadi NH; Siripongsakun S; Hicks RM; Chen J; Worakitsitisatorn A; McWilliams J; Tong MJ; Finn RS; Agopian VG; Busuttil RW; Lu DSK
Hepatology; 2017 Jun; 65(6):1979-1990. PubMed ID: 28170115
[TBL] [Abstract][Full Text] [Related]
16. Role of transarterial chemoembolization for hepatocellular carcinoma before liver transplantation with special consideration of tumor necrosis.
Schaudt A; Kriener S; Schwarz W; Wullstein C; Zangos S; Vogl T; Mehrabi A; Fonouni H; Bechstein WO; Golling M
Clin Transplant; 2009 Dec; 23 Suppl 21():61-7. PubMed ID: 19930318
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence.
Pompili M; Mirante VG; Rondinara G; Fassati LR; Piscaglia F; Agnes S; Covino M; Ravaioli M; Fagiuoli S; Gasbarrini G; Rapaccini GL
Liver Transpl; 2005 Sep; 11(9):1117-26. PubMed ID: 16123960
[TBL] [Abstract][Full Text] [Related]
18. Multimodal treatment for hepatocellular carcinoma on cirrhosis: the role of chemoembolization and alcoholization before liver transplantation.
Troisi R; Defreyne L; Hesse UJ; Praet M; Decruyenaere J; De Hemptinne B
Clin Transplant; 1998 Aug; 12(4):313-9. PubMed ID: 9686325
[TBL] [Abstract][Full Text] [Related]
19. Comparison of clinical outcomes in chronic hepatitis B liver transplant candidates with and without hepatocellular carcinoma.
Wong SN; Reddy KR; Keeffe EB; Han SH; Gaglio PJ; Perrillo RP; Tran TT; Pruett TL; Lok AS
Liver Transpl; 2007 Mar; 13(3):334-42. PubMed ID: 17154401
[TBL] [Abstract][Full Text] [Related]
20. Priority of candidates with hepatocellular carcinoma awaiting liver transplantation can be reduced after successful bridge therapy.
Cucchetti A; Cescon M; Bigonzi E; Piscaglia F; Golfieri R; Ercolani G; Cristina Morelli M; Ravaioli M; Daniele Pinna A
Liver Transpl; 2011 Nov; 17(11):1344-54. PubMed ID: 21837731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
